Development and evaluation of a vancomycin dosing nomogram to achieve the target area under the concentration-time curve. A retrospective study.

Adult Aged Aged, 80 and over Anti-Bacterial Agents / pharmacokinetics Area Under Curve Body Weight Creatinine / blood Dose-Response Relationship, Drug Drug Monitoring Female Glomerular Filtration Rate Humans Male Middle Aged Nomograms Retrospective Studies Vancomycin / pharmacokinetics Young Adult
Area under the concentration-time curve Nomogram Pharmacokinetics Therapeutic drug monitoring Vancomycin

Journal

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375

Informations de publication

Date de publication:
May 2020
Historique:
received: 04 10 2019
revised: 14 11 2019
accepted: 26 11 2019
pubmed: 28 12 2019
medline: 11 11 2020
entrez: 28 12 2019
Statut: ppublish

Résumé

Although the superiority of vancomycin dosing based on area under the concentration-time curve (AUC

Identifiants

DOI: 10.1016/j.jiac.2019.11.009 PMID: 31879186
pubmed: 31879186
pii: S1341-321X(19)30366-6
doi: 10.1016/j.jiac.2019.11.009
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Vancomycin 6Q205EH1VU
Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

444-450

Informations de copyright

Copyright © 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

Kazutaka Oda (K)

Department of Pharmacy, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, Japan; Department of Infection Control, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, Japan. Electronic address: kazutakaoda@kuh.kumamoto-u.ac.jp.

Tomomi Katanoda (T)

Department of Pharmacy, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, Japan; Department of Infection Control, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, Japan. Electronic address: sy05044@kuh.kumamoto-u.ac.jp.

Yumi Hashiguchi (Y)

Department of Pharmacy, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, Japan. Electronic address: yumihashi@kuh.kumamoto-u.ac.jp.

Shoji Kondo (S)

Department of Pharmacy, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, Japan; Department of Infection Control, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, Japan. Electronic address: kondo.shoji@kuh.kumamoto-u.ac.jp.

Yuki Narita (Y)

Department of Pharmacy, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, Japan. Electronic address: y-nari@kuh.kumamoto-u.ac.jp.

Koji Iwamura (K)

Department of Pharmacy, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, Japan. Electronic address: kouji-iwamura@kuh.kumamoto-u.ac.jp.

Kisato Nosaka (K)

Department of Infection Control, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, Japan. Electronic address: knosaka@kumamoto-u.ac.jp.

Hirofumi Jono (H)

Department of Pharmacy, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, Japan. Electronic address: hjono@kuh.kumamoto-u.ac.jp.

Hideyuki Saito (H)

Department of Pharmacy, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto, Japan. Electronic address: saitohide@kuh.kumamoto-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Development and evaluation of a vancomycin...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Development and evaluation of a vancomycin...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Sujet âgé de 80 ans ou plus › Development and evaluation of a vancomycin...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Development and evaluation of a vancomycin...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Aire sous la courbe › Development and evaluation of a vancomycin...
questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Croissance › Mensurations corporelles › Poids › Development and evaluation of a vancomycin...
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Imidazoles › Créatinine › Development and evaluation of a vancomycin...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes toxicologiques › Relation dose-effet des médicaments › Development and evaluation of a vancomycin...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Monitorage physiologique › Surveillance des médicaments › Development and evaluation of a vancomycin...
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques des voies urinaires › Débit de filtration glomérulaire › Development and evaluation of a vancomycin...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Development and evaluation of a vancomycin...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Development and evaluation of a vancomycin...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Modèles statistiques › Nomogrammes › Development and evaluation of a vancomycin...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études rétrospectives › Development and evaluation of a vancomycin...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Glycopeptides › Vancomycine › Development and evaluation of a vancomycin...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Jeune adulte › Development and evaluation of a vancomycin...